Clinical Trial Update: Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation Myocardial Infarction [Phase 4]

View source ↗

Summary

Phase 4 trial update on a half-dose bolus of recombinant staphylokinase (r-SAK) given before primary PCI in ST Elevation Myocardial Infarction; the study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• r-SAK (recombinant staphylokinase)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: ST Elevation Myocardial Infarction | Phase 4 | Status: RECRUITING